On Monday, Soleno Therapeutics Inc (NASDAQ: SLNO) opened lower -4.13% from the last session, before settling in for the closing price of $47.17. Price fluctuations for SLNO have ranged from $41.50 to $90.32 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 20.19% annually for the last half of the decade. Company’s average yearly earnings per share was noted 104.29% at the time writing. With a float of $49.27 million, this company’s outstanding shares have now reached $53.70 million.
Soleno Therapeutics Inc (SLNO) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Soleno Therapeutics Inc is 8.27%, while institutional ownership is 117.17%. The most recent insider transaction that took place on Aug 11 ’25, was worth 110,696,581. Before that another transaction happened on Jul 01 ’25, when Company’s insider sold 3,830 for $82.76, making the entire transaction worth $316,971. This insider now owns 13,206 shares in total.
Soleno Therapeutics Inc (SLNO) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -1.27 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -1.08) by -0.19. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.68 per share during the current fiscal year.
Soleno Therapeutics Inc (NASDAQ: SLNO) Trading Performance Indicators
Check out the current performance indicators for Soleno Therapeutics Inc (SLNO). In the past quarter, the stock posted a quick ratio of 15.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 24.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.84, a number that is poised to hit 0.62 in the next quarter and is forecasted to reach 4.11 in one year’s time.
Technical Analysis of Soleno Therapeutics Inc (SLNO)
Let’s dig in a bit further. During the last 5-days, its volume was 1.45 million. That was inferior than the volume of 1.75 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 24.89%.
During the past 100 days, Soleno Therapeutics Inc’s (SLNO) raw stochastic average was set at 8.07%, which indicates a significant increase from 1.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.93 in the past 14 days, which was lower than the 3.35 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $51.66, while its 200-day Moving Average is $67.22. However, in the short run, Soleno Therapeutics Inc’s stock first resistance to watch stands at $46.93. Second resistance stands at $48.63. The third major resistance level sits at $49.52. If the price goes on to break the first support level at $44.34, it is likely to go to the next support level at $43.45. The third support level lies at $41.75 if the price breaches the second support level.
Soleno Therapeutics Inc (NASDAQ: SLNO) Key Stats
There are currently 53,710K shares outstanding in the company with a market cap of 2.43 billion. Presently, the company’s annual sales total 0 K according to its annual income of -175,850 K. Last quarter, the company’s sales amounted to 66,020 K and its income totaled 26,010 K.
